# Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease

> **NCT01677871** · NA · UNKNOWN · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 120 (estimated)

## Conditions studied

- Chronic Liver Disease With Tuberclosis

## Interventions

- **DRUG:** 2HRZE/4HR
- **DRUG:** 2HRLE/4HR
- **DRUG:** 9HLE
- **DRUG:** 9RLE

## Key facts

- **NCT ID:** NCT01677871
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2013-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01677871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01677871, "Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01677871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*